Filter By Category
Archives
Share on -
APADOLINE
Generic Name: APADOLINE
ABSTRACT -
Apadoline is an investigational small-molecule kappa-opioid receptor agonist.
It has been studied for analgesic and visceral pain-related indications.
No approved routine dosing regimen is established.
DOSAGE -
- Dosage should be determined only by a qualified healthcare professional.
- No approved standard dosing regimen is established for this API.
- Doses, route, premedication, monitoring, and dose modifications must follow the applicable clinical-trial or specialist protocol.
- Do not use outside an approved study, compassionate-use program, or authorized regulatory setting.
SIDE EFFECTS–
- Possible side effects may include:
- Dizziness
- Somnolence
- Nausea
- Vomiting
- Dysphoria or mood changes
- Sedation
- Constipation
- Potential psychotomimetic effects typical of kappa agonists
ALLERGIC REACTIONS -
- Hypersensitivity to the active compound or excipients is possible.
- Symptoms may include skin rash, urticaria, pruritus, facial swelling, wheezing, dizziness, or anaphylaxis.
- Patients with a suspected allergic reaction should stop treatment and seek urgent medical attention.
DRUG INTERACTIONS–
- Alcohol, opioids, benzodiazepines, sedatives, and other CNS depressants may increase impairment.
- Other opioid-active medicines may alter analgesic or adverse effects.
- Use caution with drugs that affect alertness or respiratory function.
PREAUTIONS–
- Assess substance-use history and psychiatric history.
- Avoid driving or hazardous tasks until response is known.
- Use caution in hepatic impairment and respiratory disease.
- Pregnancy and lactation safety are not established.
WARNINGS –
- Not approved for clinical use.
- CNS impairment and mood changes can occur.
- Use only under research supervision.
Share on -
. Developed by